Date: Wednesday 5 July 2006
Time: 08:00 - 17:30
Venue: Medical Teaching Centre, Gibbett Hill Campus
The symposium is being run as part of the AC21 International Forum.
The symposium will provide a major opportunity to improve treatment of patients arising from the fact that treatment response can be influenced by individual differences in tissue regulation and drug effectiveness. Differences in treatment response may for example arise from genetic and resulting proteomic differences in drug transporters, receptors and in pathways for drug action. Occurrence of adverse drug reactions (ADRs) can also be associated with genetic differences linked to poor drug metabolism. Pharmacogenetic and pharmacoproteomic profiling thus carries the potential to improve earlier selection of effective drug treatments, to reduce incidence of ADRs and to reduce pressures on medical services. The aim of the symposium is to consider ways in which recent developments in genomics and in proteomics can applied to effective personalised medicine profiling in clinical practice and to consider issues important in implementing into practice the necessary health technology innovations.